CONSUMER NEWS    RECALLS    COMPLAINT FORM    SCAM ALERTS  


Complain about a product or service

Small Claims Guide | Class Actions | Lemon Law | FAQ | Resources | Newsletters | Spanish
Automotive    Education    Electronics    Family    Finance    Health    Homeowners    Shopping    Travel   
NEWS   Latest |  Archives |  Auto |  Cells, etc. |  Computers |  Financial |  Health |  Homeowners |  Parents |  Privacy |  Scams |  Seniors |  Travel

Class Action Charges Botox Killed, Injured Consumers

Allergan failed to adequately warn of dangers, suit claims





July 10, 2008


FDA Cracks Down on Illegal Botox Scammers
Do-It-Yourself Botox Not a Good Idea
Class Action Charges Botox Killed, Injured Consumers
Botox Maker Subpoenaed By Justice Department
FDA Issues Botox Warning
Public Citizen Wants Stricter Botox Warnings
A New Wrinkle: Botox Users May Become "Addicted"
---
Consumer Complaints

Botox users and their families have filed a class action lawsuit against Allergan, claiming the company failed to adequately warn users of the drug's dangers.

The suit claims the toxin-based drug killed at least three people, including a seven-year-old girl with cerebral palsy who got Botox injections to help control spasticity in her limbs.

The U.S. Food and Drug Administration said in February that Botox was being injected at an alarming rate among children, especially those who are being treated for limb spasticity associated with cerebral palsy.

It noted that neither Botox nor a similar product, Myobloc, was approved for such use in the U.S. and said there have been deaths associated with the usage of the two treatments among children.

In March, Allergan said it had received a subpoena from the U.S. Justice Department seeking documents regarding Botox promotional practices. The company said its understanding was that the inquiry involves questions regarding alleged off-label promotion relating to the use of Botox for the treatment of headache.

The FDA said in February that it knew of no deaths among adults but the class action, filed in California's Orange County Superior Court, said a 69-year-old Texas nurse and a 71-year-old woman both died after receiving Botox injections.

The nurse had been receiving injections for neck and shoulder pain, while the 71-year-old, who lived in Arizona, was taking Botox at a mall clinic for wrinkles around her mouth. The suit says she had trouble breathing and swallowing after the treatment and died a short time later.

All three of the cases involved uses of Botox that are not approved by the FDA.

The suit also charges that Botox left at least 12 other patients with a range of disabilities, including some who were taking the drug for approved uses, such as smoothing frown lines.

Botox and Myobloc are designed to block nerve impulses to certain muscles, causing them to relax. Both products are approved to treat cervical dystonia, or uncontrolled muscle contractions of the neck and shoulder muscles. Botox is also approved for cosmetic use to treat wrinkles between the eyebrows and to help control excessive underarm sweating.

In some cases, the toxic, active ingredient in Botox and Myobloc -- a derivative of botulism toxin Type A, one of the deadliest poisons known -- can affect respiratory muscles and cause difficulty swallowing, a condition known as dysphagia. Both products warn doctors and consumers of that side effect.

The the FDA said in February that what is new is that it appears the active ingredient in Botox can spread from distant parts of the body -- such as children's leg muscles -- to muscles that affect breathing rather than being just a local event as previously believed.

In January, the consumer group Public Citizen said it found 16 deaths reported with usage of Botox or Myobloc from November 1997 through 2006. The group filed a petition with the FDA seeking the agency's strictest black-box warning discussing difficulty swallowing, pneumonia as a result of food getting into the lungs and, in rare instances, death from pneumonia.

The suit charges that several of the plaintiffs were hospitalized and now suffer from chronic, life-altering conditions, including difficulty swallowing.

"Thousands of people are getting these injections with no warning to speak of," said Ray Chester, one of the lawyers representing plaintiffs in the suit.

Allergan maintains the drug is safe and says millions of people have taken it with no problems.



Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.


Consumer News

September 7 2008

Recent Recalls & Safety Alerts



FREE CONSUMER NEWSLETTERS

The Daily Consumer
Afternoons M-F

Sign up now!


Consumer News & Alerts
Every Sunday

Sign up now!


Knowledge is free.
Knowledge is power.







Back to the top |

Advertisement


Home | Complaint Form | News | Recalls | FAQ |
Consumer Resources | Small Claims Guide | Lemon Law | Newsletter | Contact Us
Advertise With Us | Testimonials | Newsroom | RSS Feeds |


Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2003-2008 ConsumerAffairs.com Inc.  All Rights Reserved.    The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission.